ORIANA CIANI

University of Exeter Medical School

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Vito Domenico Bruno

University of Bristol

UNITED KINGDOM

View details

Michael Drummond

UNITED KINGDOM

View details

Gary Collins

Professor of Medical Statistics

University of Oxford

UNITED KINGDOM

View details

Gérard de Pouvourville

Chair Professor, Health Systems

ESSEC Business School

FRANCE

View details

Sylwia Bujkiewicz

Professor of Biostatistics

University of Leicester

UNITED KINGDOM

View details

Anthony Manyara

University of Bristol

UNITED KINGDOM

View details

Marilia Antunes

Professora Auxiliar

Faculdade de Ciências da Universidade de Lisboa

PORTUGAL

View details

Werner Brouwer

professor of health economics (as of 2008)

Erasmus University Rotterdam

NETHERLANDS

View details

Maria Cucciniello

Associate Professor

Bocconi University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ORIANA CIANI

Research Interests

Explore related searches

Contact this professor

Articles (24)

Collaborative Funding Model to Improve Quality of Care for Metastatic Breast Cancer in Europe

A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) Collaboration

Enhancing reporting and interpretation of surrogate endpoints in rehabilitation randomized controlled trials: a scoping review

Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment

Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impact

Design and Features of Pricing and Payment Schemes for Health Technologies: A Scoping Review and a Proposal for a Flexible Need-Driven Classification

Mapping Payment and Pricing Schemes for Health Innovation: Protocol of a Scoping Literature Review

Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?

Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial

Which behaviour change techniques work best for diabetes self-management mobile apps? Results from a systematic review and meta-analysis of randomised controlled trials

Surrogate endpoints: a key concept in clinical epidemiology

Correction: Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)

Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)

An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations

The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022

Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient’s satisfaction with therapy: The CINDERELLA trial

Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017–2022

How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?

Evaluating Barriers and Facilitators to the Uptake of mHealth Apps in Cancer Care Using the Consolidated Framework for Implementation Research: Scoping Literature Review

The role of patient-reported outcomes in reimbursement decisions and drug innovation in Italy

Direct healthcare costs of non-metastatic castration-resistant prostate cancer in Italy

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials

Disability weights for castration-resistant prostate cancer: an empirical investigation

Surrogate end points in cardio-thoracic trials: a call for better reporting and improved interpretation of trial findings

Collaborators (9)

Vito Domenico Bruno

Michael Drummond

Gary Collins

Gérard de Pouvourville

Sylwia Bujkiewicz

Anthony Manyara

Marilia Antunes

Werner Brouwer

Maria Cucciniello

Make your next move.